Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry

International Journal of Pharmaceutics

Volumn 393, Issue 1-2, 2010, Pages 75-79

  Gaisford, Simon ^a,b   Dennison, Mansa ^a   Tawfik, Mahmoud ^a   Jones, Matthew D ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Tredomen Business and Technology Centre   (United Kingdom)

Author keywords

Amorphous content; Isothermal calorimetry; Micronising; Particle size reduction; Salbutamol sulphate

Indexed keywords

SALBUTAMOL SULFATE;

ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; HUMIDITY; ISOTHERMAL TITRATION CALORIMETRY; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; TEMPERATURE;

EID: 77953361917     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.04.004     Document Type: Article

References (17)

1. Amorji J.-P., Saluja V., Petersen A.H., Hinrichs W.L.J., Huckriede A., Frijlink H.W. Pulmonary delivery of an insulin-stabilised influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. Vaccine 2007, 25:8707-8717.
2. Brodka-Pfeiffer K., Langguth P., Graβ P., Hausler H. Influence of mechanical activation on the physical stability of salbutamol sulphate. Eur. J. Pharm. Biopharm. 2003, 56:393-400.
3. Brodka-Pfeiffer K., Häusler H., Graβ P., Langguth P. Conditioning following powder micronization: influence on particle growth of salbutamol sulphate. Drug Dev. Ind. Pharm. 2003, 29:1077-1084.
4. Buckton G., Darcy P., Greenleaf D., Holbrook P. The use of isothermal microcalorimetry in the study of changes in crystallinity of spray-dried salbutamol sulphate. Int. J. Pharm. 1995, 116:113-118.
5. Chow A.H.L., Tong H.H.Y., Chattopadhyay P., Shekunov B.Y. Particle engineering for pulmonary delivery. Pharm. Res. 2007, 24:411-437.
6. Columbano A., Buckton G., Wikeley P. A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy. Int. J. Pharm. 2002, 237:171-178.
7. Feeley J.C., York P., Sumby B.S., Dicks H. Determination of surface properties and flow characteristics of salbutamol sulphate, before and after micronisation. Int. J. Pharm. 1998, 172:89-96.
8. Gaisford S., Ramos R. Calorimetry for amorphous content quantification. Eur. Pharm. Rev. 2007, 3:46-52.
9. Gorny M., Jakobs M., Mykhaylova V., Urbanetz N.A. Quantifying the degree of disorder in micronized salbutamol sulfate using moisture sorption analysis. Drug Dev. Ind. Pharm. 2007, 33:235-243.
10. Hogan S.E., Buckton G. The quantification of small degrees of disorder in lactose using solution calorimetry. Int. J. Pharm. 2000, 207:57-64.
11. Jones M.D., Harris H., Hooton J.C., Shur J., King G.S., Mathoulin C.A., Nichol K., Smith T.L., Dawson M.L., Ferrie A.R., Price R. An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances. Eur. J. Pharm. Biopharm. 2008, 69:496-507.
12. Murnane D., Marriott C., Martin G.P. Crystallisation and crystallinity of fluticasone propionate. Cryst. Growth Des. 2008, 8:2753-2764.
13. Newell H.E., Buckton G., Butler D.A., Thielmann F., Williams D.R. The use of inverse phase gas chromatography to measure the surface energy of crystalline, amorphous and recently milled lactose. Pharm. Res. 2001, 18:662-666.
14. 2-antagonist and a corticosteroid. Pharm. Res. 2009, 26:2657-2666.
15. Ramos R., Gaisford S., Buckton G. Calorimetric determination of amorphous content in lactose: a note on the preparation of calibration curves. Int. J. Pharm. 2005, 300:13-21.
16. Schiavone H., Palakodaty S., Clark A., York P., Tzannis S.T. Evaluation of SCF-engineered particle-based lactose blends in passive dry powder inhalers. Int. J. Pharm. 2004, 281:55-66.
17. Telko M., Hickey A.J. Dry powder inhaler formulations. Respir. Care 2005, 50:1209-1227.